Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients

Journal of Virological Methods

Volumn 143, Issue 1, 2007, Pages 23-28

  Mhiri, Leila ^a   Kaabi, Belhassen ^b   Houimel, Mehdi ^c   Arrouji, Zakia ^a   Slim, Amine ^a  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

^b PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^c Vaccinology   (Tunisia)

Author keywords

Antigenemia; Cytomegalovirus; Hybrid capture; qPCR

Indexed keywords

ANTIVIRUS AGENT; CYTOMEGALOVIRUS ANTIGEN PP65; DNA HYBRID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; HUMAN; IMMUNOCOMPROMISED PATIENT; KIDNEY GRAFT; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIGENS, VIRAL; BONE MARROW TRANSPLANTATION; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY TRANSPLANTATION; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUNISIA; VIRAL LOAD; VIRAL MATRIX PROTEINS;

CYTOMEGALOVIRUS;

EID: 34249316185     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.01.033     Document Type: Article

References (27)

1. Baillie G.M. Prevention of cytomegalovirus disease in solid organ transplant patients: prophylactic versus preemptive therapy. Am. J. Health Syst. Pharm. 63 19 Suppl. 5 (2006) S10-S16
2. Boeckh M., and Boivin G. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin. Microbiol. Rev. 11 3 (1998) 533-554
3. Cohen J. A coefficient of agreement for nominal scales. Educ. Psychol. Meas. 20 (1960) 37-46
4. Efron B. Better bootstrap confidence intervals (with discussion). J. Am. Stat. Assoc. 82 (1987) 171-200
5. Emery V.C., Sabin C.A., Cope A.V., Gor D., Hassan-Walker A.F., and Griffiths P.D. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 355 9220 (2000) 2032-2036
6. George, M.J., Snydman, D.R., Werner, B.G., Griffith, J., Falagas, M.E., Dougherty, N.N., Rubin, R.H., 1997. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune Inc. Gaithersburg, Maryland. Am. J. Med. 103 (2), 106-113.
7. Gerna G., Percivalle E., Torsellini M., and Revello M.G. Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytes. J. Clin. Microbiol. 36 12 (1998) 3585-3589
8. Griffiths P.D. CMV as a cofactor enhancing progression of AIDS. J. Clin. Virol. 35 4 (2006) 489-492
9. Griffiths, P.D., Whitley, R.J., 2000. Recommendations from the IHMF Management Strategies Workshop and Eighth Annual Meeting of the IHMF, The Challenge of CMV Infection and Disease in Transplantation. Cambridge Medical Publications, Worthing, United Kingdom (available at: http://www.ihmf.org).
10. Holm S. A simple sequentially rejective multiple test procedure. Scan. J. Stat. 6 (1979) 65-70
11. Humar A., Gregson D., Caliendo A.M., McGeer A., Malkan G., Krajden M., Corey P., Greig P., Walmsley S., Levy G., and Mazzulli T. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation 68 9 (1999) 1305-1311
12. Husni R.N., Gordon S.M., Longworth D.L., Arroliga A., Stillwell P.C., Avery R.K., et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin. Infect. Dis. 26 3 (1998) 753-755
13. ® 6.2 for Windows Professional Edition. Seattle, USA.
14. Kusne S., Grossi P., Irish W., St. George K., Rinaldo C., Rakela J., and Fung J. Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation 68 8 (1999) 1125-1131
15. Ljungman P., Griffiths P., and Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin. Infect. Dis. 34 8 (2002) 1094-1097 (Review)
16. Ljungman P., and Stanley P.A. Workshop on cytomegalovirus disease: definitions, clinical severity scores and new syndromes. Scand. J. Infect. Dis. 99 (1995) 87-89
17. Machado C.M., Dulley F.L., Boas L.S., Castelli J.B., Macedo M.C., Silva R.L., Pallota R., Saboya R.S., and Pannuti C.S. CMV pneumonia in allogeneic bone-marrow transplants recipients undergoing early treatment of pre-emptive ganciclovir therapy. Bone Marrow Transplant. 26 4 (2000) 413-417
18. Mutimer D., Mirza D., Shaw J., O'Donnell K., and Elias E. Enhanced (cytomegalovirus) viral replication associated with septic bacterial complications in liver transplant recipients. Transplantation 63 10 (1997) 1411-1415
19. Podzamczer D., Ferrer E., Garcia A., Ramon J.M., Niubo J., Santin M., Rufi G., Perez J.L., Martin R., and Gudiol F. pp65 antigenemia as a marker of future CMV disease and mortality in HIV-infected patients. Scand. J. Infect. Dis. 29 3 (1997) 223-227
20. Schenker N., and Gentleman J.F. On judging the significance of differences by examining overlap between confidence intervals. Am. Statistician 55 (2001) 182-186
21. Sia I.G., Wilson J.A., Groettum C.M., Espy M.J., Smith T.F., and Paya C.V. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation. J. Infect. Dis. 18 2 (2000) 717-720
22. Snydman D.R. The case for cytomegalovirus prophylaxis in solid organ transplantation. Rev. Med. Virol. 16 5 (2006) 289-295 (Review)
23. The T.H., van der Bij W., van den Berg A.P., van der Giessen M., Weits J., Sprenger H.G., and van Son W.J. Cytomegalovirus antigenemia. Rev. Infect. Dis. 12 Suppl. 7 (1990) S734-S744 (Review)
24. Torrus D., Portilla J., Hernandez-Aquado I., Boix V., Plazas J., Gimeno A., Torrome M., Llopis C., Valls V., and Sanchez-Paya J. Usefulness of pp65 antigenemia for the early diagnosis of cytomegalovirus disease in patients with AIDS. Eur. J. Clin. Microbiol. Infect. Dis. 18 9 (1999) 630-635
25. Van der Bij W., and Speich R. Management of cytomegalovirus infection and disease after solid-organ transplantation. Clin. Infect. Dis. 33 Suppl. 1 (2001) S32-S37
26. Waqle A.M., Biswas J., Gopal L., and Madhavan H.N. Clinical profile and immunological status of cytomegalovirus retinitis in organ transplant recipients. Indian J. Ophthalmol. 50 2 (2002) 115-121
27. Zweiq M.H., and Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39 4 (1993) 561-577